Welcome to our dedicated page for TITAN INTERNATIONAL SEC filings (Ticker: TWI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TITAN INTERNATIONAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TITAN INTERNATIONAL's regulatory disclosures and financial reporting.
Titan International, Inc. reported higher results for the quarter ended June 30, 2026. Net sales rose 5.2% to $484 million, lifting gross profit to $74.9 million and gross margin to 15.5%. Adjusted EBITDA increased 13.3% to $34.2 million, and adjusted net income applicable to common shareholders was $6.6 million, or $0.10 per share, compared with an adjusted net loss a year earlier. Free cash flow was $26 million.
Performance varied by segment: Agricultural net sales declined 5.0% to $183.6 million with lower margins, Earthmoving/Construction grew 1.4% to $154.5 million with improved profitability, and Consumer net sales climbed 27.2% to $146.6 million with significantly higher margins. At June 30, 2026, cash and cash equivalents were $179.8 million and net debt was $413.5 million. Management currently expects third quarter sales between $440 million and $460 million and adjusted EBITDA between $27 million and $33 million, and is maintaining full‑year 2026 sales guidance of $1.85–$1.95 billion and adjusted EBITDA of $105–$115 million.
Titan International, Inc. generated higher revenue and a small quarterly profit but posted a year-to-date loss due mainly to restructuring. For the three months ended June 30, 2026, net sales were $484,766 (up from $460,830) and net income attributable to Titan shareholders was $5,764, or $0.09 per share, versus a loss in the prior-year quarter. Gross margin improved to 15.5%, helped by cost actions and $6.0 million of IEEPA tariff refund recoveries recorded as a reduction of cost of goods sold.
For the six months ended June 30, 2026, net sales were $989,839, but restructuring and impairment expenses of $25,976 tied to the planned October 2026 closure of the Jackson, Tennessee facility drove an operating loss and a net loss of $17,910. The Consumer segment showed strong growth and margin expansion, while Agricultural sales and profit declined. Titan ended the period with $179,785 of cash, total debt principal of $594,794, and availability of $43.9 million under its $225.0 million revolving credit facility.
Titan International director Richard M. Cashin Jr. received a grant of 24,725 shares of common stock at no cost, reported as a compensation-related award. These are Restricted Stock Units that vest on the first anniversary of the grant date.
Following the award, he directly holds 251,045 shares of Titan International common stock and indirectly holds 176,461 shares through the Richard M. Cashin Jr 2017 GRAT. He also holds stock options over 20,000 shares at an exercise price of $11.8450 expiring in 2028 and options over another 20,000 shares at $11.7900 expiring in 2027.
Titan International director Maurice M. Taylor Jr. reported receiving a grant of 24,725 shares of common stock as a compensation award, at a stated price of $0.00 per share. These are restricted stock units that vest on the first anniversary of the grant date.
After this award, he directly holds 677,356 shares of common stock. He also holds stock options over 20,000 underlying shares at an exercise price of $11.845, expiring on June 13, 2028, and options over 29,200 underlying shares at an exercise price of $11.79, expiring on June 14, 2027.
Guinn Max A reported acquisition or exercise transactions in this Form 4 filing.
TITAN INTERNATIONAL INC director Max A. Guinn received an equity grant of 24,725 shares of common stock as Restricted Stock Units. The RSUs vest on the first anniversary of the grant date and were recorded at a price of $0.00 per share, reflecting a stock-based compensation award rather than an open-market purchase.
Following this grant, Guinn directly holds 190,061 shares of Titan International common stock, indicating this is a routine compensation-related increase in his equity stake rather than a discretionary trading decision.
TITAN INTERNATIONAL INC director Anthony L. Soave reported an equity award that increases his share-based holdings. He received 24,725 shares of common stock in the form of Restricted Stock Units at a price of $0.00 per share, which vest on the first anniversary of the grant date.
After this award, he directly holds 1,193,348 shares of common stock and indirectly holds 5,000 shares through Brambleton Investments LLC. He also holds stock options covering 20,000 shares at an exercise price of $11.845 per share expiring on June 13, 2028, and 20,000 shares at $11.79 per share expiring on June 14, 2027.
Thompson Laura K reported acquisition or exercise transactions in this Form 4 filing.
TITAN INTERNATIONAL INC director Laura K. Thompson received an equity award in the form of restricted stock units. On the reported date, she was granted 12,362 shares of common stock at no purchase price as a compensation-related award, rather than an open-market transaction.
After this grant, Thompson directly holds 59,377 shares of Titan International common stock. The award represents restricted stock units that will vest on the first anniversary of the grant date, meaning she receives the full benefit only if she remains eligible through that period.
RACHESKY MARK H MD reported acquisition or exercise transactions in this Form 4 filing.
Titan International director Mark H. Rachesky, MD received a compensation grant of restricted stock units (RSUs). On June 23, 2026 he was awarded 24,725 RSUs tied to Titan International common stock at a reference value of $7.28 per share. According to the grant terms, these RSUs are payable upon vesting in an equal number of common shares and are scheduled to vest on June 23, 2027. The filing also reports a separate direct holding entry of 267,358 shares of common stock as of the same date.
TITAN INTERNATIONAL INC executive Max Narancich, COO of Carlstar, reported a routine tax-related share disposition. The company withheld 1,461 shares of common stock at $7.54 per share to satisfy tax withholding obligations tied to the vesting of restricted stock, rather than an open-market sale.
After this withholding, Narancich directly holds 85,737 common shares, including 64,334 shares of restricted stock. These restricted shares are scheduled to vest in tranches on 3/10/27, 6/20/27, 3/10/28, and 3/10/29, indicating ongoing equity-based compensation.
Titan International, Inc. reported the results of its annual meeting of stockholders held on June 18, 2026. Stockholders elected seven directors to one-year terms, ratified the selection of BDO USA P.C. as independent auditor for the year ending December 31, 2026, and approved a non-binding advisory resolution on 2025 executive compensation.
A total of 52,036,730 shares, or 80.83% of the 64,371,960 shares outstanding on the record date, were represented in person or by proxy. Each director nominee received more votes "for" than "withheld," the auditor ratification received over 51.7 million votes in favor, and the say-on-pay proposal received over 45.1 million votes in favor.